RecruitingNCT06976528

Understanding the Associations Between Romantic Relationship Conflict, Psychophysiological Responding and Alcohol Misuse Among Emerging Adults


Sponsor

New York University

Enrollment

160 participants

Start Date

Sep 26, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

Emerging Adults (EA) engage in heavy episodic drinking (HED) at a greater quantity and frequency than any other time in their lives, which may lead to significant short- and long-term consequences. Although much is known about the influence of peers in EA alcohol use, there is a dearth of research examining the ways in which romantic partners influence EA drinking behaviors. The proposed study bridges a crucial gap in the existing literature by examining behavioral and physiological risk and resilience factors in the acute link between EA relationship conflict and alcohol consumption. EA couples will engage in two conflict resolution tasks interspersed with two puzzle tasks and two alcohol administration procedures. Because high frequency heart rate variability (HF-HRV) is associated with alcohol use and emotion regulation during stressful experiences, HF-HRV and other physiological data will be collected throughout the laboratory procedures.


Eligibility

Min Age: 21 YearsMax Age: 29 Years

Inclusion Criteria4

  • Age 21-29 years old
  • Must be in a committed romantic relationship of at least 3 months duration
  • Must report at least 2 HED episodes in the past 30 days (5 or more drinks within 2 hours for males, 4 or more drinks within 2 hours for females)
  • Must self-report that they have - on at least three occasions during the past year - consumed a quantity of alcohol that is equal to or greater than the standard dose administered for their weight in the laboratory

Exclusion Criteria13

  • Meeting DSM-5 criteria for a history of or current neurological, psychotic, or bipolar disorders
  • History of self-reported head trauma requiring medical treatment
  • Body weight exceeding 250 pounds
  • Current enrollment in treatment or seeking treatment for a substance or alcohol use disorder
  • Current suicidal or homicidal intent
  • Serious cardiovascular health conditions (e.g. pacemaker, cardiac arrhythmia, hypertension) that may alter normative cardiac functioning
  • Treatment on medications such as lithium, methadone, alpha or beta blockers or cholinergic/anticholinergic medications likely to confound normative cardiovascular responding or response to alcohol administration. Stimulant or benzodiazepine medication use is permissible provided participants do not take medication on the day of study participation
  • Severe and/or unilateral physical IPV with your current partner at any time
  • Sexual IPV with current partner at any time
  • Fear of current partner
  • Pregnancy or breastfeeding
  • Severe Alcohol Use Disorder (as defined by the DSM-5)
  • Current diagnosis of anorexia or bulimia

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

386 Park Avenue South

New York, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06976528


Related Trials